18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: A systematic review and meta-analysis
European Journal of Radiology, 08/21/2012
Evidence Based Medicine
Clinical Article
Lin CY et al. – Based on the results of this systematic review, F–18 FDG PET (PET/CT) was useful in ruling in extrahepatic metastases of hepatocellular carcinoma (HCC) and valuable for ruling out the recurrent HCC.



